# OnCo record agenus (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/agenus/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "agenus" ;
  schema:name "Agenus"@en ;
  schema:alternateName "Agenus Inc."@en, "Agenus Inc"@en ;
  schema:description "Agenus is a Massachusetts immuno-oncology company developing botensilimab, an Fc-enhanced anti-CTLA-4 antibody, with its anti-PD-1 balstilimab, notably in microsatellite-stable colorectal cancer where checkpoint inhibitors have not worked."@en ;
  schema:url <https://onco.cc/companies/agenus/>, <https://agenusbio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Agenus> ;
  owl:sameAs <http://www.wikidata.org/entity/Q4692116> ;
  schema:citation <https://agenusbio.com>, <https://clinicaltrials.gov/search?lead=Agenus>, <https://en.wikipedia.org/wiki/Agenus> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:targets <https://onco.cc/targets/ctla4/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/botensilimab/>, <https://onco.cc/drugs/zalifrelimab/> ;
  onco:trials <https://onco.cc/trials/nct05205330/>, <https://onco.cc/trials/nct06782555/> .